Aktie TJBH TENGJUN BIOTECHNOLOGY CORP.
Zu einer Liste hinzufügen
Um diese Funktionalität nutzen zu können, müssen Sie Mitglied sein
EinloggenRegistrieren
Inaktiver Wert

Andere Sprachen Tengjun Biotechnology Corp. Other OTC

Aktien

TJBH

US88035C1071

TJBH

Andere Sprachen

Suchen
Ergebnisse ansehen
Schalten Sie alle Nachrichten frei: Seien Sie als Erster informiert und reagieren Sie vor den Märkten!
100% kostenlose Registrierung
Tengjun Biotechnology Corp. Announces Chief Executive Officer Changes
Tengjun Biotechnology Corp. Announces Chief Financial Officer Changes
Tengjun Biotechnology Corp. Announces Board Changes
Tengjun Biotechnology : Change in Certifying Accountants - Form 8-K
Tengjun Biotechnology Corp. Announces CEO Changes
Tengjun Biotechnology Corp. Announces CFO Changes
Tengjun Biotechnology Corp. Announces Board Changes
Glancy Prongay & Murray LLP, a Leading Securities Fraud Law Firm, Announces Investigation of Tengjun Biotechnology Corp. (TJBH) on Behalf of Investors
ROSEN, A GLOBALLY RESPECTED LAW FIRM, Encourages Tengjun Biotechnology Corp. Investors to Inquire About Securities Class Action Investigation – TJBH
Tengjun Biotechnology Corp. Reports Earnings Results for the Second Quarter and Six Months Ended June 30, 2023
Tengjun Biotechnology : Non-Reliance on Previously Issued Financial Report - Form 8-K
Tengjun Biotechnology Corp. Resolves to Appoint Ms. Caihong Qu as the Interim Chief Executive Officer
Tengjun Biotechnology Corp. Resolves to Appoint Ms. Caihong Qu as Interim Chief Financial Officer
Tengjun Biotechnology Corp. Resolves to Appoint Ms. Caihong Qu as A Member of the Board
Tengjun Biotechnology Corp. Announces Demise of Xianchang Ma, Chief Executive Officer
Tengjun Biotechnology Corp. Announces Xianchang Ma, Chief Financial Officer, Passed Away
Tengjun Biotechnology Corp. Announces demise of Xianchang Ma, Director
Tengjun Biotechnology Corp. Reports Earnings Results for the First Quarter Ended March 31, 2023
TENGJUN BIOTECHNOLOGY CORP. : Other Events (form 8-K)
TENGJUN BIOTECHNOLOGY CORP. MANAGEMENT'S DISCUSSION AND ANALYSIS OF FINANCIAL CONDITION AND RESULTS OF OPERATIONS (form 10-K)
Keine Ergebnisse zu dieser Suche
Alle Nachrichten Analystenempfehlungen Wichtige Fakten Insiders Transkripte Pressemitteilungen Offizielle Publikationen Andere Sprachen Trading-Ideen MarketScreener Artikel MarketScreener Analysen

Filter

Suchen

Datum der Veröffentlichung

Vom

Bis

  1. Börse
  2. Aktien
  3. A3DRZQ Aktie
  4. TJBH Aktie
  5. Nachrichten Tengjun Biotechnology Corp.
  6. Andere Sprachen
-40 % Einmalige Verlängerung: Unsere Abonnements führen Sie zu den besten Investitionen von morgen
PROFITIEREN SIE JETZT